Metropolitan Life Insurance Company (MetLife)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,718
Closed -$8.41K 2368
2022
Q1
$8.41K Sell
11,718
-30,430
-72% -$21.8K ﹤0.01% 2234
2021
Q4
$95.3K Sell
42,148
-6,066
-13% -$13.7K ﹤0.01% 2514
2021
Q3
$139K Buy
48,214
+20,259
+72% +$58.3K ﹤0.01% 2331
2021
Q2
$106K Sell
27,955
-15,693
-36% -$59.5K ﹤0.01% 2570
2021
Q1
$148K Buy
43,648
+21,502
+97% +$72.8K ﹤0.01% 2217
2020
Q4
$62K Buy
22,146
+3,550
+19% +$9.94K ﹤0.01% 2454
2020
Q3
$46.7K Sell
18,596
-21,577
-54% -$54.2K ﹤0.01% 2473
2020
Q2
$546K Buy
40,173
+3,313
+9% +$45K 0.01% 1137
2020
Q1
$279K Sell
36,860
-1,711
-4% -$13K 0.01% 1389
2019
Q4
$244K Buy
38,571
+8,808
+30% +$55.7K ﹤0.01% 1779
2019
Q3
$117K Sell
29,763
-5,319
-15% -$20.9K ﹤0.01% 2218
2019
Q2
$170K Buy
35,082
+2,690
+8% +$13K ﹤0.01% 1995
2019
Q1
$265K Sell
32,392
-11
-0% -$90 ﹤0.01% 1708
2018
Q4
$179K Buy
32,403
+11,644
+56% +$64.4K ﹤0.01% 1896
2018
Q3
$183K Hold
20,759
﹤0.01% 2061
2018
Q2
$207K Buy
20,759
+6,578
+46% +$65.6K ﹤0.01% 1921
2018
Q1
$135K Hold
14,181
﹤0.01% 2132
2017
Q4
$211K Sell
14,181
-15,760
-53% -$234K ﹤0.01% 1882
2017
Q3
$589K Buy
29,941
+6,117
+26% +$120K ﹤0.01% 1572
2017
Q2
$342K Sell
23,824
-7,516
-24% -$108K ﹤0.01% 1969
2017
Q1
$288K Sell
31,340
-460
-1% -$4.23K ﹤0.01% 2033
2016
Q4
$331K Hold
31,800
﹤0.01% 2028
2016
Q3
$288K Sell
31,800
-2,182
-6% -$19.8K ﹤0.01% 2091
2016
Q2
$254K Hold
33,982
﹤0.01% 2161
2016
Q1
$306K Buy
33,982
+15,346
+82% +$138K ﹤0.01% 1886
2015
Q4
$241K Buy
18,636
+16,684
+855% +$216K ﹤0.01% 2111
2015
Q3
$19K Sell
1,952
-16,938
-90% -$165K ﹤0.01% 2657
2015
Q2
$194K Buy
+18,890
New +$194K ﹤0.01% 2421
2014
Q3
Sell
-9,285
Closed -$258K 2661
2014
Q2
$258K Buy
+9,285
New +$258K ﹤0.01% 2324